ProCE Banner Activity

Targeted Therapies for Biliary Tract Cancers

Slideset Download
Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors and targeted therapies to treat patients with advanced biliary tract cancers.

Released: November 12, 2021

Expiration: November 11, 2022

No longer available for credit.

Share

Faculty

Mark Yarchoan

Mark Yarchoan, MD

Assistant Professor
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

Mark Yarchoan, MD

Assistant Professor
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins
Baltimore, Maryland

Mark Yarchoan, MD, has disclosed that he has received consulting fees from AstraZeneca, Eisai, and Exelixis and funds for research support _x000b_(paid to his institution) from Bristol-Myers Squibb, Exelixis, Genentech/Roche, and Incyte.